Why Perform a Bubble Study in Numbness and Central Midline Pain?
A bubble study is performed to detect a paradoxical embolism through a right-to-left shunt (patent foramen ovale or pulmonary arteriovenous malformation), which can cause stroke or transient ischemic attack presenting as numbness and neurological symptoms. 1, 2
The Clinical Rationale
When a patient presents with numbness and central symptoms suggestive of cerebrovascular events, the concern is for embolic stroke. The bubble study (agitated saline contrast echocardiography) is specifically designed to identify pathways through which venous clots can bypass the normal pulmonary filter and reach the arterial circulation, causing stroke.
What the Bubble Study Detects
The agitated saline creates microbubbles that normally get trapped in the pulmonary capillaries. If bubbles appear in the left atrium within 3-5 cardiac cycles, this indicates an intracardiac shunt (typically patent foramen ovale). If bubbles appear after 5-8 cardiac cycles, this suggests an intrapulmonary shunt such as a pulmonary arteriovenous malformation. 3, 1
Key Diagnostic Distinctions
Timing of Bubble Appearance:
- Early (3-5 cycles): Intracardiac shunt (PFO, atrial septal defect)
- Late (>5-8 cycles): Intrapulmonary shunt (PAVM, hepatopulmonary syndrome)
- No appearance: No right-to-left shunt detected
Clinical Significance in Stroke Workup
Patent foramen ovale is present in 25-30% of the general population but becomes clinically relevant when paradoxical embolism is suspected. 2 The presence of a PFO in patients with massive PE increases the risk of stroke by 5.9-fold and peripheral arterial embolism by 15-fold. 2
The bubble study is more sensitive than Doppler echocardiography alone for detecting low-velocity right-to-left shunts. 1 It has a sensitivity of 98-99% for detecting intrapulmonary shunts when performed correctly. 3
When to Order This Test
The bubble study should be performed when:
- Cryptogenic stroke or TIA occurs (stroke without identified cause after standard workup)
- Young patients (<60 years) present with stroke
- Stroke occurs with evidence of deep vein thrombosis
- Refractory hypoxemia exists with liver disease (hepatopulmonary syndrome)
- Multiple small infarcts suggest embolic source
Important Caveats
The test should be performed with proper technique using well-agitated saline with a few drops of blood to prevent air introduction. 1 The patient should perform a Valsalva maneuver or cough during injection to increase right atrial pressure and unmask transient right-to-left shunts that may not be apparent at rest.
Safety Considerations
While generally safe, there are rare reports of cerebral ischemic events occurring during bubble studies (incidence approximately 0.1%). 4, 5 These complications occur almost exclusively in patients who already have cardiac or pulmonary shunts—the very condition being tested for. Informed consent should be obtained, acknowledging this small but real risk. 5
Recent evidence using neuron-specific enolase as a marker suggests the procedure does not cause silent neuronal injury in patients without underlying neurological susceptibility. 6
Clinical Impact on Management
Detection of a PFO or intrapulmonary shunt fundamentally changes management:
- Anticoagulation vs antiplatelet therapy decisions
- Consideration for percutaneous PFO closure (particularly in recurrent cryptogenic stroke)
- Identification of pulmonary AVMs requiring embolization 3
- Recognition of hepatopulmonary syndrome requiring liver transplant evaluation 7
However, it's worth noting that in one study, only 31% of patients with detected PFO had subsequent management changes, suggesting the test is sometimes overutilized in patients with readily identifiable stroke causes. 5 The test should be reserved for patients with cryptogenic events or those without obvious alternative stroke mechanisms.